Pathological Section 67 in the world outside, and that the bacteria, torula and moulds, whose appearance is so ubiquitous, must be constantly originating as well as multiplying all around us. We should, moreover, no longer have to postulate the existence everywhere in the atmosphere of inconceivably numerous and varied germs, always ready suitably to tenant every new possibility in the way of site, however unusual it may be.' To meet such requirements the atmosphere ought to present itself as infinitely more crowded with germs of the most varied kinds than it has ever been found to be by the many persons who have most carefully examnined it from this point of view.
THE work which has been done with the Wassermann reaction in connexion with the diagnosis of syphilis and the regulation of the treatment thereof prompted us to apply the knowledge gained therefrom in order to ascertain whether parallel results could be obtained in gonococcal systemic infections. Our technique of the complement-fixation test did not depart in any way from the original, but we found it wiser to employ a little stronger solution of complement than is required for the Wassermann reaction owing to the avidity for fixing complement which most bacillary emulsions possess. We also used the patients' *sera diluted 1 in 5 instead of 1 in 10, so as to avoid overlooking a serum which only contained a little antibody.
The antigen being the most important part of the experiment requires special consideration. Only twenty-four to forty-eight hours cultures on freshly prepared ascitic fluid or pleural fluid agar were used. The resulting growth was emulsified in normal saline containing 05 per cent. phenol, and the strength of the emulsion found, by counting against normal blood according to Wright's method. As a rule 300 to 500 million per cubic centimetre were about the limits between which the strength of the emulsion was adapted to the successful working of the test. We employed altogether fifteen different strains of gonococci and were always careful to use only those emulsions prepared from the original culture, or first subculture, as those obtained from lower subcultures give indifferent results. The emulsions, if required for further use, should be stored in the dark at 0°C. Under these conditions they appear to remain little impaired for ten days, but then they begin to lose their power of combining with the specific antibody.
In this respect different strains vary, as one of our emulsions retained its antigen properties for considerably longer.
In every series of tests one known positive and one known negative sera were included. For the latter we tested altogether from thirty to forty sera of normal persons and of patients suffering from diseases other than gonorrhoea, but in no single case was any fixation of comlplement noted. For the former we eilmployed a serum with which we had already obtained a triple plus, and in addition we used Burroughes and Wellcome's antigonococcal serum, which was obtained from a horse which had been immunized with subcutaneous injections of cultures; with such a serum a triple plus result was invariably obtained in dilutions up to 1 in 10. Sera remain active for at least a fortnight if kept undiluted in the dark at 0°C. in sealed pipettes, but after a time they become amphoteric, a property which can sometimes be destroyed by re-inactivating for half an hour to an hour.
Differences exist between the several strains of the gonococcus as regards their capacity for fixing complement in the presence of the specific amboceptor, so it occurred to us to inquire as to whether these differences related to the nature of the gonorrhoeal infection from which the strain was isolated. One of our best strains both as regards its antigen and vaccine properties was obtained from a case of acute anterior urethritis, which was cured in ten days with injections of potassium permanganate as the sole treatment. On the other hand, an antigen prepared from a culture from the heart's blood of a fatal case of gonococcal septicaemia was by no means so active. Again, one strain was grown from a subacute case of urethritis in a male of average severity; the culture was not by any means abundant, but was undoubtedly the true gonococcus. The emulsion of this culture failed entirely to fix complement in the presence of a known triple plus serum.
It appears to be the case, therefore, that no definite relation can be traced between the nature of the case from which a strain of gonococcus is derived and the properties of this strain as tested by the com-plement-fixation test. Such a conclusion is quite in harmony with the known facts with regard to the relative virulence of strains of the diphtheria bacillus or the typhoid bacillus. For example, strains of the diphtheria bacillus from such a mild affection as membranous rhinitis have been shown to have a marked virulence when injected into guineapigs. Hence it may be inferred that the relative virulence of any given strain of the gonococcus is not the chief factor in determining the severity or mildness of the infection. There must be other factors, such, for example, as the resistance of the infected individual, the site of entrance of the micro-organism (the different streptococcal diseases produced by the Streptococcus pyogenes according to the path by which it finds an entrance into the body), and the quantity of the virus which is implanted upon the host. It likewise shows that a vaccine prepared from a strain obtained from a severe case will not necessarily be a potent one. Our next step was to try to determine the relationship between an emulsion as an antigen in the complement-fixation test and the same emulsion as a vaccine. An emulsion of gonococci is an " antigen "i.e., contains the bacterial bodies and endotoxins which when inoculated into the living organism give rise to the formation of a specific antagonistic substance or antibody. The term "antigen," perhaps unhappily, is also commonly used to denote that factor in the complement-fixation test which combines with the antibody. The term in both cases is applied to the same thing, the bacterial emulsion, but to two different effects of it, one manifested in the living organism, the other in the experiment in vitro. Nevertheless, it is a probable inference that an emulsion of bacteria which has a high antigen value in the test in vitro will also have a high antigen value when injected into a living animal or patient. We have found in practice that the emulsions which most completely fixed complement (in the presence of positive sera) were most likely to provide potent vaccines: therefore gonococcal vaccines can be standardized by determining their antigen value in vitro.
A curious phenomenon encountered may be briefly alluded to in this place. One of the patients whose serum was repeatedly examined was a man, A. K., aged 22, suffering from severe gonorrhceal arthritis of many joints. His serum at intervals of over a month always gave a triple plus with several antigens, with ore exception-viz. the strain of gonococcus isolated from his own urethra after prostatic massage. With this strain the fixation of complement was incomplete.
VACCINES.
All that has been said of our method of obtaining the cultures, making and counting the emulsions for the antigen in the complementfixation tests, applies to the preparation of vaccines; in fact, many of the strains were used for both purposes. Emulsions intended for use as vaccines were, however, autolysed for twenty-four hours at 370 C. to kill the gonococci. No heat was employed. The gonococcus rapidly autolyses at blood heat, and no living cocci remain at the end of twenty-four hours.
Three methods of vaccine treatment were employed and regulated by the complement-fixation test.
(I) Vaccines injected Subcutaneously in the usual way.
Therapeutic Efects.-Such vaccines we found rarely failed to produce a certain reaction, sometimes a marked reaction, even in the moderate doses we employed. We should not have been prepared to inject them in the large doses sometimes advocated, and are inclined to believe that the stock vaccines which can with impunity be employed in doses of several thousand million must be either old preparations or made from strains attenuated by repeated subculture. We did not use autogenous vaccines. In the chronic cases with arthritis, which formed the bulk of our cases, such a proceeding was difficult, if not impossible. In general we are of opinion that it is far more important in gonorrhoea to use a vaccine recently made from an original culture or first subculture than to lay a great stress on the vaccine being autogenous. Two preparations on the market were also employed for subcutaneous infection-viz., " gonargin " and " arthigon." Tested by the complement-fixation test method gonargin showed the presence of antigen, though not to anything like the extent to which it was present in our freshly made emulsions. Arthigon had -very feeble properties as a vaccine, and in the complement-fixation test no definite result could be obtained unless the emulsion was so diluted as to make the test valueless. The emulsion per se fixed complement to an extraordinary degree, so that we made little use of the " arthigon " preparation for treatment, for the above reasons. An increase is produced temporarily in the discharge in many cases with all the ordinary subcutaneous vaccines we have employed, and this temporary increase tends to diminish with each succeeding injection. A negative phase almost invariably occurs after every subcutaneous injection, and its duration depends upon the dose used and the interval which elapses between each dose. One case was given 506 gonargin on three successive days, with the result that the complement-fixation test did not return to positive as it was before the first dose was given for three weeks, during which time the discharge increased and the epididymitis lighted up again. If, then, vaccines are to be used subcutaneously, or, better, intramuscularly, as by this route the local reaction is prevented, only small doses should be employed and longer intervals should be allowed between the succeeding injections, than is generally advised. The dose should range from 5 to 10 million, and should not be repeated for a fortnight or even longer; then each future interval can be gradually shortened as the duration of the negative phase diminishes.
(II) Intravenous Injections of Vaccine.
Having ascertained how to obtain active vaccines for subcutaneous injection, our next experiments were directed to the use of them intravenously. We made use of an autolysed emulsion containing originally 1,000 million gonococci per cubic centimetre. -It had been kept in a sealed tube at 0°C. for more than three weeks. On centrifugalization the amount of deposit was very slight. A comparatively old emulsion was purposely preferred to a more recent one, as being more completely autolysed and containing more of the active principle in solution. Obviously, it might not be thought advisable to inject intravenously an emulsion containing bacterial bodies, even though dead. The supernatant fluid was pipetted off and ascertained by culture to be sterile. It was then tested for complement fixation in the presence of a known triple plus serum. Compared with a recent emulsion, which we had in use at the time, it had lost some of its power, but retained sufficient to justify its use as a vaccine. We therefore started to use it in comparatively large doses-viz., 5 million. In diluting down, the fluid was reckoned as equal to 1,000 million per cubic centimetre, and the smaller doses calculated accordingly. Each injection was given in 5 oz. of saline, as by using a large bulk of fluid a more general distribution would be achieved.
Effect of Inijections.-The above sterile fluid injected subcutaneously in doses of 10 million was followed by little reaction and good therapeutic effect. Intravenous injections in smaller doses produced no reaction, and the beneficial effect was marked, even in doses of 1 million. It is not necessary to exceed a dose of 20 million. Probably, even with 5 or 10 million, as good results are obtained. The doses we used were probably too big. It might be better to start with 1 million and then gradually increase by 1 million weekly. Contrary to what might be expected, the negative phase is negligible (judged by clinical signs and the serum reaction) after intravenous vaccine, provided not too big a dose has been given. In this respect intravenous vaccines are preferable to subcutaneous.
Effect on the Patient's Serum as shown by the Fixation of Complement.-The patients treated by the intravenous injection of vaccine were mnostly those who had given a strong positive reaction in the complementfixation test. Following the injections the reaction underwent variations, very much in the way that the serum reaction is changed in syphilis by salvarsan. During the course of intravenous vaccine injections the positive reaction in favourable cases becomes less positive, sometimes returns for a time to a strong positive, and again becomes yet more diminished in intensity, until finally it becomes negative. The average number of injections required to obtain a negative reaction is about ten. Sometimes even that number is insufficient. If too big doses are given the complementfixation test becomes negative, but the symptoms are aggravated, and when the latter have quietened down the reaction becomes positive again.
(III) Sensitized Vaccines.
Preparation of the Sensitized Vaccine. -This was carried out according to the method recommended by Besredka. The bacterial emulsion of a fresh living culture is counted. It should be of strong emulsion (never less than 1,000 million per cubic centimetre). To a measured amount of this (2 c.c. for example) about 1 c.c. of the inimune serum is added. (Besredka prefers to use as little antibody as is compatible with sensitization.) The mixture is left at room temperature for twelve hours, by which time the bacteria are deposited at the bottom of the tube. The serum is now pipetted off and replaced with saline. The tube is shaken and then centrifuged. The saline is then pipetted off and replaced by more, and the tube again centrifuged. The deposit of bacteria washed free of serum is finally made up to the original bulk with 0 5 per cent. phenol saline, and this constitutes the sensitized vaccine.
THE IMMUNE SERUM USED IN SENSITIZING.
(I) Immune Horse Serum.
Burroughes and Wellcome's antigonococcus serum, the serum of a horse immunized by subcutaneous inoculation with several strains of gonococcus. This serum gave complete fixation of complement; it was used, as already mentioned, as one of our triple plus controls. It contained much antibody, therefore it was reasonable to suppose that it was well adapted to the preparation of a sensitized vaccine. This expectation, however, was not realized. The first experiments we made with this sensitized vaccine were unsatisfactory. Local reactions were not pronounced; improvement was noted in the joints or other foci of infection, and no negative phase occurred; but bad general effects were produced, the patients had diffuse pains and felt ill, and rises of temperature occurred.
(II) Human Immune Serum.
In consequence of these bad effects we decided to continue with sensitized vaccine, but in preparing it to use for immune serum human serum taken from the vein of a gonorrhceal patient. Such a serum was obtained from a case taken at a time when it gave a strong positive result in the complement-fixation test subsequent to six intravenous injections of the autolysed vaccine with doses at weekly intervals of 5 to 20 million. The sensitized vaccine made with this serum behaved very differently from that prepared with the immune horse serum. Not only did the symptoms of the disease disappear more quickly, but the reactions were practically nil, and no toxic phenomena occurred. As with the last described vaccine, no negative phase was produced; we have also had good results with a vaccine sensitized with fluid obtained from a gonococcal joint which we had demonstrated to be fairly rich in antibody.
THE SUPERIORITY OF GoNOCOCCAL VACCINE SENSITIZED WITH HUMAN IMMUNE SERUM OVER THAT SENSITIZED .WITH IMMUNE HORSE SERUM.
The causes of this marked difference seem to us to be as follows:
The gonococcal emulsion contains probably two constituents: (a) the killed bacteria themselves; (b) endotoxins liberated from them.
To produce a completely sensitized vaccine, which will not exert any deleterious effects, it is necessary to employ an immune serum which will combine with or neutralize both (a) and (b)-in other words, the immune serum should contain both a bactericidal substance and an " anti-endotoxin." Now we know from our experiments that the immune horse serum did undoubtedly contain some specific antibody which gave a strong complement-fixation test, but since toxic symptoms followed its use it may be inferred that the immune horse serum contains, on the other hand, no anti-endotoxins. These soluble products remaining uncombined cause the ill-effects which are so constant after the administration of the subcutaneous and intravenous injections of ordinary vaccine. The human immune serum, on the other hand, contains all the antagonistic substances elaborated in the course of the natural disease. These will include both bactericidal substances and anti-endotoxin, since the micro-organisms are living and multiplying in the body, while at the same time some of them are continually being destroyed and setting free their endotoxins.
We employed our sensitized yaccines by giving doses of 20, 50, and 100 million on three successive days; in some cases it appears that one trio is sufficient to cure the case, but in the majority the symptoms ultimately recur, and as the complement-fixation test becomes less positive about the third week, it is wiser to repeat a trio of 200, 300 and 500 million between the second and third week.
We tested the fluid obtained from a joint on three occasions. In every instance it was sterile, no antigen could be demonstrated, but all gave a positive complement-fixation test; in two the reaction was as positive in the knee-joint fluid as it was in the blood. We also used the fluid obtained for therapeutic purposes, but no improvement followed when subcutaneous injections were given around an infected joint.
In conclusion, we would like to warn you to be careful in your selection of an immune serum for sensitizing purposes, since sera vary according to how much antibody they can anchor on to the antigen; therefore a vaccine should not be passed as sensitized unless the serum used for the process has become robbed of its antibody, which can be estimated by the complement-fixation test. Forty-eight hours after second injection Day of third injection (ten days after second)... Forty-eight hours after third injection .. Day of fourth injection (seven days after third)
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